Please login to the form below

Not currently logged in
Email:
Password:

Synergy Studio continues to grow

Mohamed Alani joins team in Richmond

synergy

Healthcare communs agency Synergy welcomes a new graphic designer to its growing studio.  

Having studied Industrial Design & Technology at Brunel University, Mohamed Alani (pictured) has joined the team in Richmond following a stint in the entertainment and beauty sector.

Luke Cole, studio director said: “Mo brings essential outside experience from the product and graphic design field.  He will be working closely with our teams to generate creative ideas and designs that will maximise the impact of our client solutions.”

Synergy Studio complements Synergy’s scientific offering by contributing creative and smart solutions to clients.

Ailsa Stewart, UK managing director at Synergy said: “Having an in-house studio function gives numerous benefits to our clients, allowing us to communicate data and messages in the most effective way, ensuring our medical education programmes have the edge they need to deliver with high impact, whatever the medium.”

Stewart added: “This brings the number of new Synergy recruits to 14 already this year across the agency, and we have plans to continue to build our team inside and outside the studio.”

13th June 2019

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics